These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8382276)

  • 1. Suramin is a potent inhibitor of calcemic hormone- and growth factor-induced bone resorption in vitro.
    Farsoudi KH; Pietschmann P; Cross HS; Peterlik M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):579-83. PubMed ID: 8382276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
    Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin inhibits bone resorption and reduces osteoblast number in a neonatal mouse calvarial bone resorption assay.
    Walther MM; Kragel PJ; Trahan E; Venzon D; Blair HC; Schlesinger PH; Jamai-Dow C; Ewing MW; Myers CE; Linehan WM
    Endocrinology; 1992 Nov; 131(5):2263-70. PubMed ID: 1425426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclic-AMP antagonist adenosine-3',5'-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitro.
    Ljunggren O; Ljunghall S
    Biochem Biophys Res Commun; 1993 Jun; 193(3):821-6. PubMed ID: 8391806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine A inhibits bone resorption in cultured neonatal mouse calvaria.
    Klaushofer K; Hoffmann O; Stewart PJ; Czerwenka E; Koller K; Peterlik M; Stern PH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):584-90. PubMed ID: 3500299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation.
    Regmi A; Fuson T; Yang X; Kays J; Moxham C; Zartler E; Chandrashekhar S; Galvin RJ
    Bone; 2005 Feb; 36(2):284-91. PubMed ID: 15780954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant gamma-interferon inhibits prostaglandin-mediated and parathyroid hormone-induced bone resorption in cultured neonatal mouse calvaria.
    Peterlik M; Hoffmann O; Swetly P; Klaushofer K; Koller K
    FEBS Lett; 1985 Jun; 185(2):287-90. PubMed ID: 3922796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the inhibitory effect of nonsteroidal antiinflammatory drugs on bone prostaglandin synthesis and resorption.
    Klaushofer K; Hoffmann O; Czerwenka E; Leis HJ; Gleispach H; Koller K; Peterlik M
    J Rheumatol; 1988 Mar; 15(3):486-91. PubMed ID: 3379625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
    Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
    Uchiyama S; Yamaguchi M
    Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR; Bradley SV; Fuchshuber S; Conover CA
    Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms involved in prostaglandin-induced increase in bone resorption in neonatal mouse calvaria.
    Gardner CR; Blanqué R; Cottereaux C
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):117-25. PubMed ID: 11237479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor alpha in particulate-induced bone resorption.
    Algan SM; Purdon M; Horowitz SM
    J Orthop Res; 1996 Jan; 14(1):30-5. PubMed ID: 8618163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of parathyroid hormone as a therapy for osteoporosis.
    Rubin MR; Bilezikian JP
    Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flurbiprofen derivatives HCT1026 and HCT1027 inhibit bone resorption by a mechanism independent of COX inhibition and nitric oxide production.
    Idris AI; Del Soldato P; Ralston SH; van't Hof RJ
    Bone; 2004 Sep; 35(3):636-43. PubMed ID: 15336599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal formulation, Yukmi-jihang-tang-Jahage, regulates bone resorption by inhibition of phosphorylation mediated by tyrosine kinase Src and cyclooxygenase expression.
    Jin UH; Kim DI; Lee TK; Lee DN; Kim JK; Lee IS; Kim CH
    J Ethnopharmacol; 2006 Jul; 106(3):333-43. PubMed ID: 16513308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.